Susquehanna International Group
EDSA icon

Susquehanna International Group’s Edesa Biotech EDSA Stock Holding History

Susquehanna International Group’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,610
Closed -$35.6K – 12625
2025
Q3 		$35.6K Buy
+14,610
New +$33.8K ﹤0.01% 11947
2023
Q1 		– Sell
-2,173
Closed -$32.9K – 12744
2022
Q4 		$32.9K Buy
+2,173
New +$16.2K ﹤0.01% 11592
2018
Q2 		– Sell
-80
Closed -$19K – 9745
2018
Q1 		$19K Buy
+80
New +$19.8K ﹤0.01% 9125

Other funds holding EDSA

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group's EDSA Position: Q4 2025 in Review

Susquehanna International Group sold out of Edesa Biotech (EDSA) in Q4 2025, closing a stake of 14,610 shares — an estimated $35.6K sold.

Susquehanna International Group first reported a position in EDSA in Q1 2018 and held it in 3 quarters. The position peaked at $35.6K in Q3 2025. 22 funds tracked by Wall St. Rank hold EDSA as of Q4 2025.

  • Susquehanna International Group reported no remaining Edesa Biotech position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 14,610 Edesa Biotech shares in Q4 2025, an estimated $35.6K.
  • Susquehanna International Group first reported a position in Edesa Biotech in Q1 2018 and held it in 3 quarters.
  • Susquehanna International Group's Edesa Biotech position peaked at $35.6K in Q3 2025.
  • 22 funds tracked by Wall St. Rank held Edesa Biotech as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.